Keyword: Moderna

Reserach & Innovation

New Covid Shots Score Points against Omicron

27.06.2022 -

Sanofi and GSK are touting their latecomer protein-based Covid-19 vaccine as a potential game changer in the fight against the Omicron variant.


FDA Panel to Review Pediatric mRNA Covid Vaccines

24.05.2022 -

Somewhat later than expected, the US may soon be able to offer Covid-19 vaccinations for children five years of age and younger, something parents have repeatedly...


New Moderna Covid Shot may Trigger Stronger Response

26.04.2022 -

An updated version of Moderna’s Covid-19 vaccine is claimed to produce a stronger immune response against major variants of the coronavirus, including omicron and delta...

Markets & Companies

After the Big Covid-19 Storm

19.04.2022 -

What does 2022 hold for the biopharma industry? Which companies can play at the forefront in terms of products as well as business? Covid-19 will continue to be a...


FDA Panel Meeting to Discuss Covid Vaccine Boosters

22.03.2022 -

The US Food and Drug Administration has scheduled a virtual meeting of its scientific advisory panel for Apr. 6 to discuss the prospect of future Covid-19 boosters and...


Moderna Plans Vaccines for 15 Indications

14.03.2022 -

Moderna has announced it will begin conducting human trials for vaccines against 15 threatening viruses and other pathogens by 2025 as part of a global public health...


Moderna Expands European and Asian Network

18.02.2022 -

US biotech Moderna has announced plans to expand in Europe and Asia. The expansions come as the company continues to scale up manufacturing and distribution of its Covid...


UK Gives the Final OK for Novavax Covid Shot

04.02.2022 -

February kicked off with a major publicity coup for US vaccine maker Novavax, based in the state of Maryland. Its Covid-19 vaccine was granted conditional marketing...